ReviewMaterials (Basel, Switzerland)2026
Polyhydroxybutyrate (PHB): Critical Perspectives on Material Properties, Production Advances, and Challenges Toward Sustainable Commercialisation.
Review in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Polyhydroxybutyrate (PHB), a microbial polyester belonging to the polyhydroxyalkanoate (PHA) family, has emerged as one of the most promising biodegradable alternatives to conventional petroleum-derived plastics. Its inherent marine biodegradability (typically mineralizing within months depending on material geometry and ambient temperature), biocompatibility, and ability to be synthesised from renewable and waste-derived feedstocks position PHB as a key candidate for supporting the transition towards a circular bioeconomy. Despite these advantages, widespread commercial adoption remains limited by high production costs, processing challenges, and performance constraints relative to established commodity plastics and competing biopolymers. This review critically evaluates the current state of PHB development from the perspective of sustainable commercialisation. Key aspects discussed include microbial biosynthesis pathways, feedstock selection, upstream fermentation strategies, downstream recovery technologies, and technoeconomic considerations influencing industrial feasibility. The intrinsic thermal, mechanical, and degradation characteristics of PHB are examined alongside modification approaches such as copolymerisation, polymer blending, plasticisation, and composite reinforcement that have been developed to overcome certain inherent physical-mechanical properties, narrow processing windows, and limited functional performance. Furthermore, characterisation methodologies, environmental degradation behaviour, and emerging industrial applications are assessed within the context of market requirements and sustainability objectives. Particular emphasis is placed on identifying the interconnected technical and economic bottlenecks that continue to hinder large-scale deployment, including feedstock costs, fermentation scalability, downstream processing expenses, and material performance trade-offs. By integrating advances across the entire PHB value chain, this review highlights current opportunities, remaining challenges, and future priorities required to enable the sustainable and economically viable commercialisation of PHB-based materials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.